Ischemia/Infarction

Heart Failure Clinics

Volumn 8, Issue 1, 2012, Pages 43-51

  Jugdutt, Bodh I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Extracellular matrix; Infarct expansion; Infarct size; Remodeling; Reperfusion injury

Indexed keywords

REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; AGING; ATHEROSCLEROTIC PLAQUE; CARDIAC PATIENT; CORONARY REPERFUSION; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; MORBIDITY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; REPERFUSION INJURY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS;

ANIMALS; DISEASE PROGRESSION; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 82955203421     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2011.08.006     Document Type: Review

References (70)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
2. Michorowski B., Senaratne P.J.M., Jugdutt B.I. Myocardial infarct expansion. Cardiovasc Rev Rep 1987, 8:42-47.
3. Michorowski B., Senaratne P.J.M., Jugdutt B.I. Deterring myocardial infarct expansion. Cardiovasc Rev Rep 1987, 8:55-62.
4. Jugdutt B.I. Identification of patients prone to infarct expansion by the degree of regional shape distortion on an early two-dimensional echocardiogram after myocardial infarction. Clin Cardiol 1990, 13:28-40.
5. Jugdutt B.I. Prevention of ventricular remodeling post myocardial infarction: Timing and duration of therapy. Can J Cardiol 1993, 9:103-114.
6. Jugdutt B.I. Prevention of ventricular remodeling after myocardial infarction and in congestive heart failure. Heart Fail Rev 1996, 1:115-129.
7. Jugdutt B.I. Ventricular remodeling post-infarction and the extracellular collagen matrix. When is enough enough?. Circulation 2003, 108:1395-1403.
8. Jugdutt B.I. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Disord 2003, 3:1-30.
9. Jugdutt B.I., Hutchins G.M., Bulkley B.H., et al. Myocardial infarction in the conscious dog: Three dimensional mapping of infarct, collateral flow and region at risk. Circulation 1979, 60:1141-1150.
10. Jugdutt B.I., Becker L.C., Hutchins G.M. Early changes in collateral blood flow during myocardial infarction in conscious dogs. Am J Physiol 1979, 237:H371-H380.
11. Tennant R., Wiggers C.J. The effect of coronary occlusion on myocardial contraction. Am J Physiol 1935, 112:351-356.
12. Lieberman A.N., Weiss J.L., Jugdutt B.I., et al. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981, 63:739-746.
13. Reimer K.A., Jennings R.B. The " wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979, 40:633-644.
14. Hutchins G.M., Bulkley B.H. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978, 41:1127-1132.
15. Eaton L.W., Weiss J.L., Bulkley B.H., et al. Regional cardiac dilation after acute myocardial infarction: Recognition by two-dimensional echocardiography. N Engl J Med 1979, 300:57-62.
16. Erlebacher J.A., Weiss J.L., Eaton L.W., et al. Late effects of acute infarct dilation on heart size: a two-dimensional echocardiographic study. Am J Cardiol 1982, 49:1120-1126.
17. Erlebacher J.A., Weiss J.L., Weisfeldt M.L., et al. Early dilation of the infarcted segment of acute transmural myocardial infarction: Role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 1984, 4:201-208.
18. Schuster E.H., Bulkley B.H. Expansion of transmural myocardial infarction: A pathophysiological factor in cardiac rupture. Circulation 1979, 60:1532-1538.
19. Eaton L.W., Bulkley B.H. Expansion of acute myocardial infarction: Its relationship to infarct morphology in a canine model. Circ Res 1981, 49:80-88.
20. Hochman J.S., Bulkley B.H. Expansion of acute myocardial infarction: an experimental study. Circulation 1982, 65:1446-1450.
21. Hochman J.S., Bulkley B.H. Pathogenesis of left ventricular aneurysms: an experimental study in the rat model. Am J Cardiol 1982, 50:83-88.
22. Jugdutt B.I., Michorowski B. Role of infarction expansion in rupture of the ventricular septum after acute myocardial infarction. A two-dimensional echocardiography study. Clin Cardiol 1987, 10:641-652.
23. Jugdutt B.I., Basualdo C.A. Myocardial infarct expansion during indomethacin and ibuprofen therapy for symptomatic post-infarction pericarditis: Effect of other pharmacologic agents during early remodeling. Can J Cardiol 1989, 5:211-221.
24. Jugdutt B.I., Khan M.I. Impact of increased infarct transmurality on remodeling and function during healing after anterior myocardial infarction in the dog. Can J Physiol Pharmacol 1992, 70:949-958.
25. Jugdutt B.I., Tang S.B., Khan M.I., et al. Functional impact on remodeling during healing after non-Q-wave versus Q-wave anterior myocardial infarction in the dog. J Am Coll Cardiol 1992, 20:722-731.
26. Weisman H.F., Bush D.E., Mannisi J.A., et al. Cellular mechanisms of myocardial infarct expansion. Circulation 1988, 78:186-201.
27. Jugdutt B.I., Becker L.C., Hutchins G.M., et al. Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog. Circulation 1981, 63:17-28.
28. Jugdutt B.I., Sussex B.A., Warnica J.W., et al. Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction with infusion of nitroglycerin. Circulation 1983, 68:1264-1273.
29. Jugdutt B.I., Warnica J.W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications: effect of timing, dosage and infarct location. Circulation 1988, 78:906-919.
30. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
31. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
32. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
33. DeWood M.A., Stifter W.F., Simpson C.S., et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986, 315:417-423.
34. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993, 87:38-52. The TIMI III Investigators.
35. Boersma E., Mercado N., Poldermans D., et al. Acute myocardial infarction. Lancet 2003, 361:847-858.
36. Jugdutt B.I. Extracellular matrix and cardiac remodeling. Interstitial fibrosis in heart failure 2004, 23-55. Springer, New York. F.J. Villarreal (Ed.).
37. Braunwald E. Protection of ischemic myocardium. Introductory remarks. Circulation 1976, 53:I1-I2.
38. Jugdutt B.I. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 1983, 68:673-684.
39. Jugdutt B.I. Intravenous nitroglycerin unloading in acute myocardial infarction. Am J Cardiol 1991, 68:52D-63D.
40. Hochman J.S., Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987, 75:299-306.
41. Boyle M.P., Weisman H.F. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 1993, 88:2872-2883.
42. Jugdutt B.I., Khan M.I., Jugdutt S.J., et al. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate. Circulation 1995, 92:926-934.
43. Jugdutt B.I. Effect of reperfusion on ventricular mass, topography and function during healing of anterior infarction. Am J Physiol 1997, 272:H1205-H1211.
44. Braunwald E., Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982, 66:1146-1149.
45. Kloner R.A., Ellis S.G., Lange R., et al. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 1983, 68(2 Pt 2):I8-15.
46. Fliss H., Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996, 76:949-956.
47. Ohno M., Takemura G., Ohno A. 'Apoptotic' myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling. Circulation 1998, 98:1422-1430.
48. Matsumura K., Jeremy R.W., Schaper J., et al. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 1998, 97:795-804.
49. Zhao M.J., Zhang H., Robinson T.F., et al. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (" stunned" ) but viable myocardium. J Am Coll Cardiol 1987, 10:1322-1334.
50. Charney R.H., Takahashi S., Zhao M., et al. Collagen loss in the stunned myocardium. Circulation 1992, 85:1483-1490.
51. 1 receptor blockade. J Card Fail 2004, 10:442-449.
52. Cleutjens J.P., Kandala J.C., Guarda E., et al. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1995, 27:1281-1292.
53. Heymans S., Luttun A., Nuyens D., et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999, 5:1135-1142.
54. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004, 61:481-497.
55. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002, 53:31-47.
56. Jugdutt B.I., Jelani A., Palaniyappan A., et al. Aging-related changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model. Effect of early therapy with an angiotensin II type 1 receptor blocker. Circulation 2010, 122:341-351.
57. Kim C.B., Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 1993, 88:2426-2436.
58. Bolognese L., Neskovic A.N., Parodi G., et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002, 106:2351-2357.
59. St John Sutton M., Pfeffer M.A., Moye L., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 1997, 96:3294-3299.
60. Maggioni A.P., Maseri A., Fresco C., et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the Gruppo Italiano per lo Studio della sSupravvivenza nell'Infarcto Miocardico (GISSI-2). N Engl J Med 1993, 329:1442-1448.
61. Honan M.B., Harrell F.E., Reimer K.A., et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990, 16:359-367.
62. Oyama J., Blais C., Liu X., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004, 109:784-789.
63. Chong A.J., Shimamoto A., Hampton C.R., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004, 128:170-179.
64. Yang J., Yang J., Ding J.W., et al. Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation 2008, 31:304-312.
65. Shimamoto A., Chong A.J., Yada M., et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006, 114(Suppl 1):I270-I274.
66. Nakagawa M., Takemura G., Kanamori H., et al. Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling. Circ Res 2008, 103:98-106.
67. Shinmura K., Tamaki K., Saito K., et al. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 2007, 116:2809-2817.
68. Mirotsou M., Zhang Z., Deb A., et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 2007, 104:1643-1648.
69. Jugdutt B.I. Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets. Curr Drug Targets 2008, 9:325-344.
70. Ali M.A., Cho W.J., Hudson B., et al. Titin is a target of matrix metalloproteinase-2. Implications in myocardial ischemia/reperfusion injury. Circulation 2010, 122:2039-2047.